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ABSTRACT 30 
Actinomycosis is a chronic infection caused by Actinomyces species 31 
characterized by abscess formation, tissue fibrosis, and draining sinuses. The 32 
spectrum of infections caused by Actinomyces species ranges from classical 33 
invasive Actinomycosis to a less invasive form of superficial skin and soft 34 
tissue infection. We present a review detailing all Actinomyces species 35 
isolated from breast infections in NHS Lothian between 2005 and 2013, 36 
Actinomyces species isolated from breast infections referred to the UK 37 
Anaerobe Reference Unit between 1988 and 2014 and cases describing 38 
Actinomyces breast infections published in the medical literature since 1994. 39 
Actinomyces species are fastidious organisms which can be difficult to identify 40 
and are likely to be under ascertained as a cause of breast infections. Due to 41 
improved diagnostic methods they are increasingly associated with chronic, 42 
recurrent breast infections and may play a more significant role in these 43 
infections than has previously been appreciated. 44 
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INTRODUCTION 54 
Actinomycosis is a chronic, invasive, progressive and often relapsing 55 
granulomatous infection caused by Gram-positive, facultatively anaerobic rod 56 
shaped bacteria belonging to the genus Actinomyces. Classical 57 
Actinomycosis in humans is typically caused by Actinomyces israelii and is 58 
characterized by deep invasive abscess formation, tissue fibrosis and draining 59 
sinuses affecting cervicofacial, thoracic, abdominopelvic areas (1). A number 60 
of more recently described Actinomyces species and Actinomyces-like 61 
organisms have been associated with less invasive superficial soft tissue 62 
infections and are isolated from abscesses at various anatomical sites (2,3,4).  63 
 Breast infections are frequently encountered in primary care and breast 64 
clinic settings. They can occur in the parenchyma of the breast or the 65 
overlying skin and may be in lactating or non-lactating breasts (5). Lactating 66 
breast infections are usually caused by Staphylococcus aureus (6). The 67 
microbial etiology of non-lactating breast infections, particularly those which 68 
are chronic or recurrent, is more variable, often polymicrobial and 69 
predominantly anaerobic (5,7). A study has demonstrated that when culture 70 
methods are used which enhance recovery of fastidious anaerobic organisms, 71 
almost 25% of recurrent breast abscesses (8 out of 33 patients) and 10% of 72 
primary breast abscesses (2 out of 19 patients) isolated Actinomyces species 73 
from non-puerperal breast infections (7). However, primary Actinomyces 74 
infection of the breast, first described by Ammentorp in 1893 (8), is generally 75 
considered to be rare. A clinical review from 1994 reported 19 cases 76 
described in the English language literature (9). Diagnosis of Actinomyces 77 
breast infection was often made following surgical intervention although the 78 
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method of diagnosis was not specified. Duration of symptoms was reported to 79 
range from 1-8 years, with two thirds of the patients presenting with recurrent 80 
abscesses. The remaining third of the patients were reported to have 81 
examination findings suggestive of malignancy. Most of the patients received 82 
extensive surgical treatment, with 11 patients undergoing a mastectomy, 83 
presumably for management of infection as only 3 were performed on patients 84 
with suspected malignancy.  Subsequent to this review, case reports and 85 
studies have been published describing a further 27 breast infections caused 86 
by Actinomyces species (table 3).  87 
Actinomyces breast infection is likely to be under ascertained in routine 88 
clinical practice, as these fastidious organisms are notoriously difficult and 89 
laborious to identify using conventional laboratory methods (2,3,4). 90 
Subsequently there is a risk that cultures of Actinomyces species are simply 91 
identified morphologically as “diphtheroids” and dismissed as skin 92 
commensals, even when grown from an abscess sample. However, new 93 
methods of identification such as matrix-assisted laser desorption ionization–94 
time of flight mass spectrometry (MALDI-TOF MS) allow rapid and reliable 95 
identification of many bacteria, including Actinomyces-like organisms 96 
(10,11,12). MALDI-TOF MS and similar technologies are increasingly being 97 
adopted by routine diagnostic laboratories worldwide (13).  98 
We present a series describing all cases of Actinomyces species 99 
isolated from breast infections at the Edinburgh Breast Unit over an 8 year 100 
period from 2005-2013. Further to this we include data from Actinomyces 101 
species isolated from breast samples which were referred to the Anaerobe 102 
Reference Unit, Cardiff between 1988 and 2013. We then summarize the 103 
 5
findings of case reports describing Actinomyces species causing breast 104 
infection published since the review from 1994 (9). 105 
 106 
 107 
MATERIALS AND METHODS 108 
Bacterial isolates. Review of electronic records of breast fluid aspirates 109 
received between 2005 and 2013 at the microbiology laboratory at the Royal 110 
Infirmary of Edinburgh identified eleven cases of breast infections with 111 
Actinomyces species and one case with the Actinomyces-like organism 112 
Actinobaculum schaali. Specimens were collected either as pus in sterile 113 
containers or on swabs (Stewarts media) and routinely transported to the 114 
laboratory. Fastidious anaerobic agar with horse blood (not pre-reduced) was 115 
used for culture, incubated in an anaerobic cabinet (80% nitrogen, 10% C02, 116 
10% hydrogen) for at least 48 hours. Until 2011, Gram-positive rods were 117 
identified using biochemical methods, generally API Coryne (bioMérieux). 118 
From 2011 onwards isolates were identified using MALDI-TOF MS (Bruker 119 
Daltonics). 120 
The UK Anaerobe Reference Unit in Cardiff, Wales (UKARU) provided 121 
details of Actinomyces isolates referred to them from hospitals throughout the 122 
UK between 1988 and 2014, where the source stated on the request form 123 
was ‘breast’ (abscess/fluid/wound). 124 
MALDI-TOF mass spectrometry. MALDI-TOF MS identification was carried 125 
out using a Bruker MicroFlex LT mass spectrometer (Bruker Daltonics) and 126 
Bruker FlexControl V3.3 software. Isolates were analyzed using a formic acid-127 
based direct, on-plate preparation method. A thin smear of organism was 128 
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applied to a target plate using a cocktail stick, allowed to dry and then 1μl of 129 
100% formic acid was placed on top and allowed to dry. This mixture was 130 
overlain with 1μl of matrix solution (cyano-4-hydroxycinnamic acid) and 131 
allowed to dry prior to analysis using the MALDI Biotyper. Manufacturer-132 
recommended cutoff scores were used for identification, with scores of >2.000 133 
indicating identification to the species level, scores between 1.700 and 1.999 134 
indicating identification to the genus level, and scores of <1.700 indicating no 135 
identification.  136 
Molecular identification. Definitive molecular identification was by 16S 137 
sequencing using the following method. 16S rDNA was extracted using a 138 
chelex resin/boiling method and amplified by PCR using the universal primers 139 
pA & pH’. After purification (Qiaquick PCR purification kit #28106, Qiagen), a 140 
second PCR reaction was performed using a primer internal to the initially 141 
amplified region (‘kk’) and dye-terminated nucleotides (Big Dye 3.1 Terminator 142 
Ready Reaction kit). After a second purification step, the sequence of bases 143 
was detected by size / dye terminator of the resulting DNA fragments (ABI, 144 
3100). The sequences were compared locally with those of other bacteria 145 
(ARU bespoke database, Bionumerics, Applied Maths) or with those listed in 146 
international databases (NCBI, BLAST®), with 16S rDNA homology of >97% 147 
used to determine bacterial species. 148 
Clinical review. Paper and electronic patient records of cases were reviewed 149 
for information on; age, smoking history, diabetes, nipple piercing, steroid use 150 
and whether the patient was lactating at the time of infection. The number of 151 
times the patient came into contact with the Edinburgh breast unit was 152 
recorded, along with examination findings and management received. 153 
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Information was collected on GP clinic appointments for breast infections, 154 
along with the type, duration and number of antibiotic courses for breast 155 
infection in the community. 156 
Literary review of published cases was completed on Pubmed and 157 
Ovid databases using the keywords: actinomyces, actinomycosis, breast, 158 
infection, abscess. Cases of Actinomyces infection of the breast published 159 
with clinical descriptions between 1994-2013 are detailed in table 3. Two 160 
cases from 1987 not included in the 1994 review (9) are included in this table. 161 
 162 
 163 
RESULTS 164 
Table 1 – Cases of Actinomyces species isolated from breast infections at the 165 
Edinburgh Breast Unit over an 8 year period from 2005-2013. 166 
 167 
Over an 8 year period (2005-2013) we identified eleven cases of breast 168 
infections at our center caused by Actinomyces species and one case with the 169 
Actinomyces-like organism Actinobaculum schaali. The predominant 170 
Actinomyces species isolated from our subgroup of patients were 171 
Actinomyces europaeus (n=5), A. neuii (n=3) and A. radingae (n=3). 172 
Identification using MALDI-TOF MS was attempted for 11 isolates and all of 173 
these correlated at species level with the definitive molecular identification, 174 
with p scores ranging between 1.779 and 2.331. Co-infecting organisms were 175 
present in half of these cases (n=6), usually unidentified ‘anaerobes’. Ten out 176 
of 12 cases (83%) had chronic, recurrent infection ranging from 2-8 (mean 177 
2.8) episodes, some over many years. Three patients had hidradenitis 178 
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suppurativa, 6 patients were smokers and 4 were diabetic with 3 of these 179 
patients having a combination of risk factors. No patients in our cohort had a 180 
lactational breast abscess and there was no record of any patients having had 181 
a nipple piercing. 182 
Case number 5 in particular highlights the difficulties associated with 183 
diagnosing and managing Actinomyces breast infections. This patient had 7 184 
episodes of breast infection and abscess formation over a 10 year period 185 
treated with short antibiotic courses. Cultures of aspirated abscess material 186 
repeatedly failed to grow organisms or were reported to grow “diphtheroids” of 187 
uncertain significance. Following a positive growth of A. radingae she 188 
received a 3 month course of antibiotics and has since had no further 189 
relapses (almost 2 years later). 190 
 191 
 192 
Table 2 – Actinomyces species isolated from breast infections  193 
referred to the UK Anaerobe Reference Unit from UK hospitals 1988-2014. 194 
 195 
Over a 26 year period (1988-2014), 61 isolates identified as Actinomyces 196 
species from breast infections were referred to the UK Anaerobe Reference 197 
Unit (UKARU) from UK hospitals. Although not considered ‘true anaerobes’, 198 
the UKARU has developed extensive expertise over many years regarding 199 
Actinomyces species. This was driven largely by a referral demand from UK 200 
users for advanced identification of clinically relevant isolates initially 201 
categorized as ‘anaerobic gram positive rods’ or ‘anaerobic coryneforms’. It is 202 
likely that the cases listed here represent only a small proportion of UK cases, 203 
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as referral of isolates to the unit is not mandatory. Unfortunately a further 204 
limitation of the referral process is that clinical information is not available for 205 
many of these cases, however a small number (n=5) state either ‘recurrent’ or 206 
‘previous breast abscess’. One case worthy of particular mention states 207 
‘recurrent breast abscess for 11 years’ from which A. radingae was isolated. 208 
 209 
 210 
Table 3 – Published cases of Actinomyces species isolated from breast 211 
infections reported with clinical details since 1994 (ref 14-28). 212 
 213 
Fifteen cases of Actinomyces breast infection were identified on literature 214 
review between 1994 and 2013, with another 12 cases (7,14) found prior to 215 
1994, not included in the Jain et al review (9). This paper therefore reports an 216 
additional 27 published cases of Actinomyces breast infection to the 19 217 
reported in 1994, although clinical details are only available for 17 of these 27 218 
cases. There was no clearly predominant Actinomyces species. Five cases 219 
reported co-infecting anaerobes (17,24) and one case Staphylococcus aureus 220 
(20), with no mention of co-infecting organisms in 11 of 17 cases. 221 
Seven cases were recurrent infections and a range of different treatment 222 
combinations were required to reach abscess resolution. This ranged from 2-3 223 
weeks of oral antibiotics, to incision and drainage with prolonged antibiotics 224 
for 2-6 months, with the most extreme being that of tumorectomy of the breast 225 
(22). As with our cohort of patients, prior to the diagnosis of Actinomyces 226 
breast infection, some patients had been repeatedly treated without success 227 
(14,17,20).  228 
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 229 
 230 
Table 4 – Combined number and species of Actinomyces breast infections 231 
from tables 1-3 and from reference 7. 232 
* Two Lothian cases had two different Actinomyces sp. isolated 233 
† Isolates referred from Lothian are removed from this column to avoid double 234 
counting 235 
‡ Published cases include 10 cases from ref 7 with no clinical details 236 
 237 
The Actinomyces species most commonly isolated from breast infections 238 
according to this combined table (n=102) are A. neuii (n=19), A. europaeus 239 
(n=18), A. turicensis (n=16), A. radingae (n=15) and A. odontolyticus (n=10). 240 
These mostly belong to the group of Actinomyces species generally 241 
considered to be less invasive, although it is noteworthy that in the Lothian 242 
and UK cohorts the cases with the greatest number of relapses all isolated A. 243 
radingae. The distribution of Actinomyces species broadly reflects previous 244 
findings regarding superficial Actinomyces soft tissue infections (2,3,4), 245 
although these studies did not look specifically at breast infections.  246 
Within the NHS Lothian and the published cases 48% (n=14) presented 247 
clinically with an abscess, 33% (n=9) presented with a breast mass, 10% 248 
(n=3) with a fistula and 7% (n=2) presented with periductal mastitis. There 249 
was an average of 2.8 episodes of infection per patient in the NHS Lothian 250 
cases. Within the published cases, excluding case 1 who had numerous 251 
yearly episodes of recurrent infection for 23 years, there was an average of 252 
1.5 episodes of Actinomyces breast infection per patient. 253 
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 254 
 255 
DISCUSSION 256 
Humans and animals are the natural reservoirs of Actinomyces species, 257 
which until recently have not been found to exist freely in nature (29). Their 258 
normal habitat is the mucosal membranes of the oropharynx, gastrointestinal 259 
tract and female genital tract. They are inherently low virulent and may rely on 260 
the presence of co-pathogens, such as anaerobic bacteria, to enhance 261 
pathogenicity (1). Disruption of the mucosal barrier is the usual precursor to 262 
infection with Actinomyces species and in the breast, the ductal system may 263 
serve as a portal of entry. Actinomycosis of the breast usually presents as a 264 
chronic, recurrent abscess which in some cases can be difficult to distinguish 265 
from inflammatory carcinoma (9,15,26). Fistulas and purulent or bloody 266 
discharge from sinuses may occur which may discharge “sulfur” granules 267 
(26). In advanced prolonged cases, fibrosis with architectural distortion of the 268 
breast tissue is present on mammography (15).  269 
The pathogenesis and true pathogenic role of various Actinomyces 270 
species isolated from breast infections and the treatment required for this has 271 
not been clearly defined. This is further complicated by the uncertain etiology 272 
of different types of chronic abscess-forming inflammatory conditions involving 273 
the breast, from which Actinomyces-like organisms can be isolated, such as 274 
granulomatous lobular mastitis, hidradenitis suppurativa and periductal 275 
mastitis. Granulomatous lobular mastitis presents as a peripheral 276 
inflammatory mass which may simulate malignancy or infection. Patients with 277 
this condition often develop multiple and recurrent abscesses. It has been 278 
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suggested that the Corynebacterium spp play a part in this condition, (30) but 279 
antibiotics effective against these organisms rarely lead to resolution of 280 
disease and thus they may not have a major etiological role. Hidradenitis 281 
suppurativa is an inflammatory disease of unclear etiology which commonly 282 
affects the axilla and groin and can also affect the skin of the lower half of the 283 
breast, resulting in recurrent episodes of abscess formation (31). Recent 284 
evidence suggests that anaerobic actinomycetes may be involved in the 285 
disease process, especially when lesions are more severe (32). Periductal 286 
mastitis is a condition linked to cigarette smoking (33) in which the subareolar 287 
ducts are damaged and become infected, often by anaerobic bacteria (34). 288 
Women may present with subareolar inflammation, abscesses and fistulas 289 
(35). Smoking has consistently been identified as a risk factor for primary 290 
breast abscess and its recurrence (5,35,36). Other factors, such as diabetes 291 
mellitus, obesity, African-American origin and nipple piercing have less 292 
consistently been associated with breast abscesses (5,35).  293 
Despite finding 12 cases over 8 years at our center, which is 294 
comparable to the number of cases described in the medical literature over 295 
the same time period, we suspect that there were many missed 296 
identifications. During the 8 year study period, we found another 15 cases in 297 
Lothian where potential Actinomyces-like organisms were isolated from 298 
recurrent breast abscesses, but further identification was not attempted and a 299 
report was sent out describing ‘diphtheroids’ of doubtful or uncertain 300 
significance. In addition, 4 out of our 12 culture positive cases had previous 301 
samples with isolates of potential Actinomyces-like organisms reported as 302 
‘diphtheroids’ of doubtful significance. This supports the assumption that 303 
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Actinomyces breast infections may easily go undiagnosed in routine clinical 304 
practice. Actinomyces species are slow to grow and notoriously difficult to 305 
identify using conventional laboratory methods, often requiring reference 306 
laboratory referral for reliable identification. When Actinomyces species do 307 
grow on culture they can resemble other diphtheroid-like Gram-positive rods, 308 
such as Corynebacterium species, many of which are considered to be part of 309 
normal skin flora. Actinomyces species which are isolated from breast 310 
abscess samples may therefore be presumptively identified in the laboratory 311 
as ‘diphtheroids’ based on their morphology and reported as ‘diphtheroids’ of 312 
doubtful or uncertain significance. However, laboratories are increasingly 313 
adopting new methods of identification, such as MALDI-TOF MS (13), which 314 
allow rapid and increasingly reliable identification of this problematic group of 315 
organisms (10,11,12). Indeed, most of the cases in Lothian were identified 316 
after 2012, which is shortly after our laboratory started using MALDI-TOF MS. 317 
With 10 cases diagnosed in 2 years of using MALDI-TOF MS compared to 2 318 
cases over 7 years without MALDI-TOF MS, it is clear that ease of 319 
identification is a major factor in the increased recognition of Actinomyces 320 
breast infections in our clinical setting. The Anaerobe Reference Unit  (ARU) 321 
has seen a similar increase in the number of isolates referred to them, with 322 
more isolates (n=26) referred to them over the last 3 years of the recorded 323 
period than had been referred over the first 20 years (n=25). Based on 324 
information from referring laboratories, this increase is almost certainly driven 325 
by an improvement in the identification of Actinomyces species due to 326 
increased use of MALDI-TOF MS. Subsequently, UK laboratories unfamiliar 327 
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with these organisms refer them to the ARU for confirmation of identification, 328 
susceptibility testing and clinical advice. 329 
Our results support previous findings that Actinomyces species can be 330 
reliably identified using MALDI-TOF MS (10,11,12), with all 12 of our tested 331 
isolates identified to species level, as confirmed by molecular testing. Five 332 
isolates were correctly identified to species level by MALDI-TOF MS despite 333 
identification scores only reaching genus level confidence (p<2.0). This is in 334 
keeping with recent evidence suggesting that the cut-off for species level 335 
identification could be reassessed and perhaps lowered to p>=1.7 for this 336 
group of organisms (10,12). 337 
We have modified the approach to how organisms from breast samples 338 
are identified in Lothian. Breast abscess samples now receive anaerobic 339 
incubation for 5 days, along with prolonged Actinomyces cultures when 340 
clinical details mention chronic or recurring infection. Any Gram-positive 341 
bacillus growing from a breast abscess sample is identified using MALDI-TOF 342 
MS and should no longer be reported as a “diphtheroid” of uncertain 343 
significance without an attempt being made to identify the organism.  344 
 The primary management of breast abscess is drainage, along with 345 
antibiotic therapy appropriate for the underlying cause of the abscess (31). 346 
When Actinomyces species are isolated, longer courses of antibiotics should 347 
be considered. Treatment of classical, invasive Actinomycosis, typically 348 
caused by Actinomyces israelii and to a lesser extent A. gerencseriae, A. 349 
meyeri, A. odontolyticus and A. viscosus/naeslundii (2,4,37), involves 350 
prolonged antibiotic therapy. Textbooks commonly advise 2-6 weeks of 351 
intravenous penicillin followed by 6-12 months of oral penicillin or amoxicillin 352 
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(38). However, there is evidence that shorter antibiotic courses of under 3 353 
months may be sufficient in some cases (39), particularly those caused by 354 
less invasive Actinomyces species, such as A. europaeus, A. funkei, A. neuii, 355 
A. radingae and A. turicensis (2,3,4,37,40). Even shorter 7-14 day courses of 356 
oral antibiotics are typically used when treating breast infections, but this is 357 
likely to be insufficient for Actinomyces associated breast infections and 358 
longer courses, in addition to surgical drainage, may be required to prevent 359 
recurrences. Actinomyces species are susceptible to many beta-lactam 360 
antibiotics, with penicillin and amoxicillin generally regarded as first choice 361 
options (38,41). However, due to the common presence of co-infecting, beta-362 
lactamase producing organisms, treatment options should ideally include 363 
beta-lactamase stable antibiotics, such as amoxicillin plus clavulanic acid 364 
(41), at least for the initial 2 weeks of treatment. Alternative agents for patients 365 
with penicillin allergy could include doxycycline or clindamycin, although there 366 
is less evidence for their efficacy (38). We suggest at least 6 weeks of 367 
antimicrobial treatment for extensive infections involving Actinomyces species 368 
or in cases where recurrences have occurred. Although some recurrent cases 369 
of Actinomyces breast infections seem to have benefited from this, it is not 370 
clear whether a longer course of antimicrobial in the first instance would have 371 
prevented relapses in these cases.  372 
 373 
 374 
 375 
 376 
CONCLUSION 377 
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Actinomyces associated breast infections are problematic, difficult to diagnose 378 
and difficult to treat. They are increasingly recognized in clinical practice, most 379 
likely due to a combination of increased awareness and improved diagnostic 380 
methods. Further studies are required to clarify the pathogenic role of 381 
Actinomyces species in various inflammatory conditions which involve the 382 
breast, such as periductal mastitis, hidradenitis suppurativa and 383 
granulomatous mastitis. These conditions all present with clinical features 384 
similar to those seen in Actinomyces breast infections. Taking into account 385 
the fastidious nature of Actinomyces species, it is quite possible that 386 
anaerobic actinomycetes are present significantly more frequently than they 387 
are found in these conditions. In particular, it is important to clarify whether 388 
longer initial courses of effective antibiotic treatment may prevent recurrences 389 
and radical surgery when Actinomyces species are isolated in association 390 
with these conditions. 391 
 392 
 393 
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Patient Year Age 
(years) / 
sex 
Risk 
factor(s) / 
PMH 
Type of 
breast 
infection 
MALDI-TOF 
identification 
(p=score) 
Molecular 
identification  
(16S sequencing) 
Co-infecting 
organisms 
No. of 
infections 
Previous potential 
Actinomyces 
isolate not 
identified as such 
by laboratory 
Comments on outcome 
(incl antibiotic treatment, surgery, resolution) 
1 2013 36 F Nil Left breast 
abscess 
Actinomyces 
radingae 
(p=2.0234) 
Actinomyces 
europaeus 
(p=1.972)  
Actinomyces radingae 
and  
Actinomyces 
europaeus  
Yes 
(Peptoniphilus 
sp.) 
1 No Good response to drainage and clindamycin. 
2 2013 52 F Diabetes Right breast 
infra-
mammary 
fold abscess 
Actinomyces 
europaeus 
(p=1.779)  
Actinomyces 
europaeus  
No 1 No Abscess aspirated and patient treated with flucloxacillin. 
Complete resolution 3 months later. 
3 2013 36 F Nil Left breast 
abscess 
Actinomyces 
odontolyticus 
(p=2.006)  
Actinomyces 
odontolyticus  
No 2 First isolate initially 
reported as 
“Diphtheroid” of 
doubtful 
significance. 
Chronic breast lump slowly increasing in size over 8 
months, initially investigated as potential malignancy. Core 
biopsy revealed changes consistent with chronic abscess 
and purulent aspirate grew Actinomyces odontolyticus. 
4 2013 26 F Nil Left breast 
abscess 
(infected 
epidermoid 
cyst) 
Actinomyces 
neuii  
(p=2.3314) 
Actinomyces neuii No 1 No Initial partial response to amoxicillin-clavulanic acid which 
was changed to ciprofloxacin due to intolerance. Apparent 
relapse which settled after 6 weeks of amoxicillin. Residual 
mass excised, pathology showed epidermoid cyst. 
5 2013 41 F Nil Left breast 
abscess 
Actinomyces 
radingae 
(p=2.0348) 
Actinomyces radingae Yes (multiple 
anaerobe 
species) 
7        
(over 10 
years) 
Yes (sample from 
2012 with 
"diphtheroids" and 
anaerobes). 
Multiple recurrences of breast abscesses, with no growth on 
culture as patient was already on antibiotics. Sample from 
2012 isolated "diphtheroids" and anaerobes. Patient's GP 
was advised to refer patient for aspiration before starting 
antibiotics if abscess recurred. This resulted in growth of 
Actinomyces radingae along with multiple anaerobe spp. 
Treated with drainage and amoxicillin-clavulanic acid and 
metronidazole for 2 weeks followed by 3 months of 
amoxicillin. No further recurrences almost 2 years later. 
6 2013 19 F Smoker / 
Hidradenitis 
suppurativa 
Breast 
abscess 
Actinomyces 
species 
(p=2.0186) 
Actinomyces species 
(closest sequence 
Actinomyces 
europaeus) 
No 1 No Breast abscess drained. Patient treated with amoxicillin-
clavulanic acid for 1 week with apparent resolution. 
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Patient Year Age 
(years) / 
sex 
Risk 
factor(s) / 
PMH 
Type of 
breast 
infection 
MALDI-TOF 
identification 
(p=score) 
Molecular 
identification  
(16S sequencing) 
Co-infecting 
organisms 
No. of 
infections 
Previous potential 
Actinomyces 
isolate not 
identified as such 
by laboratory 
Comments on outcome 
(incl antibiotic treatment, surgery, resolution) 
7 2012 34 F Smoker Left and 
right breast 
abscesses 
Actinomyces 
radingae 
(p=1.829) 
Actinomyces radingae Yes 
(Actinobaculum 
schaalii and 
multiple 
anaerobe 
species) 
8 No Multiple recurrences of breast abscesses over a period of 
12 months treated with aspirations and short courses of 
antibiotics (mostly combinations of flucloxacillin, amoxicillin-
clavulanic acid and metronidazole). Referred for mammary 
fistula and total duct excision of right breast. 
8 2012 46 F Diabetes / 
Smoker / 
Hidradenitis 
suppurativa 
Breast 
abscess 
Actinomyces 
neuii  
(p=2.076) 
Actinomyces neuii No 2 Yes (sample from 
2011 with 
"diphtheroids" and 
anaerobes). 
Abscess drained and patient treated with antibiotics. 
Previous episode in 2011 treated with amoxicillin-clavulanic 
acid and metronidazole. 
9 2012 38 F Smoker Breast 
abscess and 
periductal 
mastitis 
Actinobaculum 
schaalii  
(p=not available) 
Actinobaculum 
schaalii 
Yes 
(Streptococcus 
constellatus) 
4 (over 3 
years) 
Yes (sample from 
2011 with 
"diphtheroids" and 
alpha-haem 
streptococci). 
Recurrent left breat periductal mastitis and abscess, 4 
episodes over 3 years. Treated with antibiotics and 
sometimes aspiration.  
10 2011 - 
2012 
36 F Diabetes / 
Smoker / 
Hidradenitis 
suppurativa 
Left and 
right breast 
abscesses 
Actinomyces 
neuii  
(p=1.921) and 
Actinomyces 
europaeus 
(p=<2.0) 
Actinomyces neuii  
and  
Actinomyces 
europaeus 
Yes (Anaerobes) 2 No Two separate breast abscesses left and right breast 3 
months apart. First episode treated with multiple 7 day 
courses of flucloxacillin and/or amoxicillin. Second episode 
treated with 3 months of amoxicillin. No recurrence 18 
months later.  
11 2005 43 F Smoker Left 
periductal 
mastitis 
Not available. 
Sent to 
reference 
laboratory. 
Actinomyces 
europaeus 
Yes (Anaerobes) 2 Isolate identified as 
"Corynebacterium 
species" and sent to 
reference laboratory. 
Two episodes of periductal mastitis in 1997-98, requiring 
aspiration (no microbiological data available) and 4 weeks 
of antibiotics. Presented again in 2005 with an abscess 
requiring drainage twice 4 weeks apart. Treated with 10 
days of oral amoxicillin-clavulanic acid. 
12 2005 59 F Diabetes Left breast 
abscess 
Not available. 
Sent to 
reference 
laboratory. 
Actinomyces 
europaeus 
No Unknown Isolate identified as 
"Corynebacterium 
species" and sent to 
reference laboratory. 
Information not available. 
 
Table 2. Actinomyces species isolated from breast infections referred to  
UK Anaerobic Reference Unit from UK hospitals 1988-2014 
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Patient Country Year Age Risk factor(s) 
/ PMH 
Clinical 
description 
Organism Method of 
identification 
Co-infecting 
organisms 
No. of 
infections 
Comments on outcome 
(incl antibiotic treatment, 
surgery, resolution) 
Ref 
1 USA 1987 29 Severe 
peridental 
disease 
Hard 5x4 cm left 
breast mass 
Actinomyces 
meyerii 
Not specified Diverse 
anaerobes 
1-3 episodes 
every year 
for 23 years 
Surgical debridement with 
ampicillin, doxycyline for 4 
months 
14 
2 USA 1987 36 Recurrent 
peridental 
abscesses 
Hard 4x4 cm 
right breast 
mass 
Actinomyces 
meyerii 
Not specified Diverse 
anaerobes 
5 
recurrences 
over 3 years 
Surgical debridement with 
tetracycline, doxycycline for 
4 months 
14 
3 Brazil 2000 66 Diabetes 5 year history of 
a mass in the left 
breast. Nipple 
discharge, 
cutaneous 
fistulas. 
Actinomyces 
species 
Histopathologic 
examination. 
Culture of abscess 
4 years previously 
isolated 
Actinomyces sp. 
None mentioned 2 Abscesses and fibrous 
tissue drained and 
resected. Responded to 2 
months of IV penicillin 
followed by oral amoxicillin 
for 6 months. 
15 
4 Italy 2005 27 Nil Unilateral right 
mastitis, 
palpable 5 cm 
nodular lump just 
beside the right 
areola. 
Actinomyces 
viscosus 
Culture positive. 
Biochemical tests. 
None mentioned 1 One week of an unspecified 
antibiotic with no response. 
Then oral 
amoxicillin/clavulanic acid 
followed by surgical 
drainage and excision of the 
lesion with no further 
antibiotics. Resolution after 
6 year follow up. 
16 
5 UK 2007 33 Bilateral nipple 
piercings 
removed 6 
months prior to 
presentation. 
On 5mg 
prednisolone 
for ulcerative 
colitis, smoker. 
3 week history of 
right breast pain, 
swelling, and 
offensive nipple 
discharge. 
Actinomyces 
turicensis 
Culture positive. 
Confirmed with 
16S rDNA 
restriction analysis. 
Mixed 
anaerobes 
3 Aspiration and 
amoxicillin/clavulanic acid 
for 7 days. Worsening 
symptoms and three more 
attempts to aspirate over 
the following 2-week period. 
Incision and drainage with 
full excision of abscess wall, 
followed by ceftriaxone and 
oral metronidazole for 3 
weeks. Complete resolution 
at follow up 8 weeks later. 
17 
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Patient Country Year Age Risk factor(s) 
/ PMH 
Clinical 
description 
Organism Method of 
identification 
Co-infecting 
organisms 
No. of 
infections 
Comments on outcome 
(incl antibiotic treatment, 
surgery, resolution) 
Ref 
6 UK 2007 38 
(male) 
Ex-smoker Right axillary 
and left 
subareolar 
abscess with 
nipple discharge 
for 7 months. 
Left axillary 
abscess drained 
18 months 
previously. 
Actinomyces 
radingae 
(isolated from 
subareolar 
abscess) 
Culture positive. 
Confirmed with 
16S rDNA 
restriction analysis. 
Heavy growth of 
anaerobes (from 
right axillary 
abscess) 
3 Incision and drainage of 
abscesses. Oral amoxicillin 
and fusidic acid for 6 
weeks. Recurrence of A. 
radingae followed by a 
prolonged course of oral 
ciprofloxacin and rifampicin 
with eventual resolution. 
17 
7 France 2009 48 Pregnant Inflammatory 
breast mass 15 
mm. Clinically 
and 
radiologically 
interpreted as 
carcinoma. 
Actinomyces 
neuii 
FNA showed 
granulomas. 
Culture positive. 
Confirmed with 
'genetic 
amplification'. 
None mentioned 1 Treated with 3 weeks of oral 
amoxicillin with resolution 
18 
8 Iran 2009 30 Nil Few days history 
of sudden painful 
and swollen left 
breast with 
multiple fistula 
formation. 
Actinomyces 
israelii 
Morphology on 
culture 
None mentioned 1 Responded to treatment 
with oral erythromycin for 6 
months. 
19 
9 UK 2010 35 7 months post-
partum 
3 month history 
of tenderness 
and induration in 
the right breast 
Not isolated 
on culture 
Histopathologic 
examination 
Staphylococcus 
aureus on skin 
swab 
1 Treated with oral penicillin 
with little improvement. 
Further treatment with 
imipenem, coamoxiclav and 
metronidazole had little 
effect. Finally treated for 
over 12 months with oral 
clindamycin with resolution. 
20 
10 Iran 2010 48 Psychiatric 
problem 
2 month history 
of non-tender 
mass in the left 
breast. 
Not isolated 
on culture 
Histopathologic 
examination 
None mentioned 1 Treated with 4 weeks of 
intravenous penicillin, 
followed by oral amoxicillin 
for 4 months. Fully resolved 
at 2 year follow up. 
21 
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Patient Country Year Age Risk factor(s) 
/ PMH 
Clinical 
description 
Organism Method of 
identification 
Co-infecting 
organisms 
No. of 
infections 
Comments on outcome 
(incl antibiotic treatment, 
surgery, resolution) 
Ref 
11 France 2010 46 Nil Recurrent 
abscess with 
fistulas 
Actinomyces 
neuii 
Not specified None mentioned Recurrent 
abscesses 
No improvement with 
antibiotics. Tumorectomy of 
the breast. No recurrence 
after 6 months. 
22 
12 Spain 2010 48 Nil Painful 
erythematous 
fluctating left 
breast lump 
Actinomyces 
neuii 
Culture positive. 
Confirmed with 
16S rRNA 
sequencing 
None mentioned 1 Resolved with surgical 
debridement and a course 
of oral penicillin V 
23 
13 Switzerland 2011 67 Aortic valve 
replacement 2 
months 
previous 
3 day history of 
painful 12 cm 
swelling and 
hyperaemia of 
the left breast 
Actinomyces 
europaeus 
Culture positive. 
Confirmed with 16s 
rRNA and 16s 
rDNA sequencing  
Mixed anaerobic 
flora 
1 3 weeks of oral amoxicillin-
clavulanic acid followed by 
15 months amoxicillin. At 3 
months 3 sinuses formed. 
Resolved at follow up 6 
months later with scar 
formation. 
24 
14 India 2012 50 Nil 6 month history 
of intermittently 
discharging 6x4 
cm right breast 
mass  
Actinomyces 
israelii 
Sulphur granules. 
Morphology on 
culture. 
None mentioned 1 No information 25 
15 India 2012 61 Diabetes 6 month history 
of 5 x 6 cm mass 
in left breast 
Not isolated 
on culture  
Histopathologic 
examination 
None mentioned 1 Treated with unspecified 
antibiotics. Doing well on 
follow up. 
26 
16 India 2012 32 Nil 3 week history of 
7 x 8 cm right 
breast mass 
Not isolated 
on culture  
Histopathologic 
examination 
None mentioned 1 Resolved after a course of 
unspecified antibiotics. 
27 
17 USA 2013 40 Nil 2 week history of 
3 cm tender right 
breast mass with 
overlying 
erythema 
Actinomyces 
odontolyticus 
Not specified None mentioned 1 Cefalexin for 1 week with 
resolution after 2 weeks of 
oral penicillin V. 
28 
 
Table 4. Combined number and species of Actinomyces breast infections from tables 1-3 and 
from reference 7. 
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 Lothian cases* Anaerobe Ref 
Unit cases† 
Published 
cases‡ 
Total 
A. europaeus 5 12 1 18 
A. funkeii 0 2 0 2 
A. israelii 0 0 4 4 
A. massiliense 0 1 0 1 
A. meyerii 0 0 4 4 
A. neuii 3 13 3 19 
A. odontolyticus 1 5 4 10 
A. radingae 3 11 1 15 
A. turicensis 0 15 1 16 
A. urogenitalis 0 2 0 2 
A. viscosus 0 0 1 1 
A. species 1 0 4 5 
Actinobaculum schaalii 1 0 0 1 
Not cultured 0 0 4 4 
Total 14 61 27 102 
  
* Two Lothian 
cases had two 
different 
Actinomyces sp. 
isolated 
 
† Isolates 
referred from 
Lothian removed 
from this column 
to avoid double 
counting 
 
‡ Includes 
10 cases 
from ref 7 
with no 
clinical 
details 
 
 
